Sarah Gheuens, M.D., Ph.D.
Board Member
Viridian Therapeutics, Inc.\DE (VRDN)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Sarah Gheuens, M.D., Ph.D.
Sarah Gheuens, M.D., Ph.D. is recorded as Board Member at Viridian Therapeutics, Inc.\DE (VRDN). Viridian Therapeutics, Inc.\DE reported in an 8-K filed June 24, 2025 that Sarah Gheuens, M.D., Ph.D. was appointed Class I director, effective June 20, 2025.
“Election of the three Class I director nominees to serve until the 2028 Annual Meeting of Stockholders:”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2025-06-20–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Viridian Therapeutics, Inc.\DE
Other people whose current roles at this company are on record from its filings.
- Scott Myers CEO, Board Member
- Stephen Mahoney CEO, Board Member
- Tomas Kiselak Chairman
- Seth Harmon CFO
- Jonathan Violin COO
- Lee Rauch COO, Board Member
- Thomas Beetham COO
- Lara Meisner General Counsel
- Kristian Humer Chief Accounting Officer
- Arlene M. Morris Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.